These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27592355)

  • 1. High doses of hydroxytyrosol induce apoptosis in papillary and follicular thyroid cancer cells.
    Toteda G; Lupinacci S; Vizza D; Bonofiglio R; Perri E; Bonofiglio M; Lofaro D; La Russa A; Leone F; Gigliotti P; Cifarelli RA; Perri A
    J Endocrinol Invest; 2017 Feb; 40(2):153-162. PubMed ID: 27592355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer.
    Lin SF; Lin JD; Hsueh C; Chou TC; Wong RJ
    PLoS One; 2017; 12(2):e0172315. PubMed ID: 28207834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human beta-defensins-1-4 in thyroid cancer cells and new insight on biologic activity of hBD-2 in vitro.
    Zhuravel OV; Gerashchenko OL; Khetsuriani MR; Soldatkina MA; Pogrebnoy PV
    Exp Oncol; 2014 Sep; 36(3):174-8. PubMed ID: 25265350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
    Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
    Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the endothelin axis in the proliferation of human thyroid cancer cells.
    Donckier JE; Mertens-Strijthagen J; Flamion B
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):552-6. PubMed ID: 17561979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential roles of leptin in regulating cell migration in thyroid cancer cells.
    Cheng SP; Yin PH; Chang YC; Lee CH; Huang SY; Chi CW
    Oncol Rep; 2010 Jun; 23(6):1721-7. PubMed ID: 20428831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the proteasome as a promising therapeutic strategy in thyroid cancer.
    Wunderlich A; Arndt T; Fischer M; Roth S; Ramaswamy A; Greene BH; Brendel C; Hinterseher U; Bartsch DK; Hoffmann S
    J Surg Oncol; 2012 Mar; 105(4):357-64. PubMed ID: 22006286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer.
    Wang S; Lloyd RV; Hutzler MJ; Safran MS; Patwardhan NA; Khan A
    Mod Pathol; 2000 Aug; 13(8):882-7. PubMed ID: 10955455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effects of arsenic trioxide in transformed human thyroid cells.
    Fröhlich E; Czarnocka B; Brossart P; Wahl R
    Thyroid; 2008 Nov; 18(11):1183-93. PubMed ID: 19014326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis.
    Fabiani R; De Bartolomeo A; Rosignoli P; Servili M; Montedoro GF; Morozzi G
    Eur J Cancer Prev; 2002 Aug; 11(4):351-8. PubMed ID: 12195161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
    De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S
    J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment.
    Camacho CP; Latini FR; Oler G; Hojaij FC; Maciel RM; Riggins GJ; Cerutti JM
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):475-83. PubMed ID: 18727708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells.
    Landriscina M; Maddalena F; Fabiano A; Piscazzi A; La Macchia O; Cignarelli M
    Anticancer Res; 2010 Feb; 30(2):473-80. PubMed ID: 20332457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
    Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
    J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
    Furuya F; Lu C; Willingham MC; Cheng SY
    Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Hydroxytyrosol Induces the Death for Apoptosis of Human Melanoma Cells.
    Costantini F; Di Sano C; Barbieri G
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 protein expression in human thyroid gland and thyroid cancer.
    Temmim L; Ebraheem AK; Baker H; Sinowatz F
    Anat Histol Embryol; 2006 Apr; 35(2):125-9. PubMed ID: 16542178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxytyrosol promotes superoxide production and defects in autophagy leading to anti-proliferation and apoptosis on human prostate cancer cells.
    Luo C; Li Y; Wang H; Cui Y; Feng Z; Li H; Li Y; Wang Y; Wurtz K; Weber P; Long J; Liu J
    Curr Cancer Drug Targets; 2013 Jul; 13(6):625-39. PubMed ID: 23597197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.